LZK Polyclonal Antibody

    • Catalog No.:YT2610
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse;Rat
      • Target:
      • LZK
      • Fields:
      • >>MAPK signaling pathway
      • Gene Name:
      • MAP3K13
      • Protein Name:
      • Mitogen-activated protein kinase kinase kinase 13
      • Human Gene Id:
      • 9175
      • Human Swiss Prot No:
      • O43283
      • Mouse Swiss Prot No:
      • Q1HKZ5
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human M3K13. AA range:151-200
      • Specificity:
      • LZK Polyclonal Antibody detects endogenous levels of LZK protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:20000.. IF 1:50-200
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • MAP3K13;LZK;Mitogen-activated protein kinase kinase kinase 13;Leucine zipper-bearing kinase;Mixed lineage kinase;MLK
      • Observed Band(KD):
      • 108kD
      • Background:
      • The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase contains a dual leucine-zipper motif, and has been shown to form dimers/oligomers through its leucine-zipper motif. This kinase can phosphorylate and activate MAPK8/JNK, MAP2K7/MKK7, which suggests a role in the JNK signaling pathway. [provided by RefSeq, Jul 2008],
      • Function:
      • catalytic activity:ATP + a protein = ADP + a phosphoprotein.,cofactor:Magnesium.,enzyme regulation:Activated by autophosphorylation and homodimerization.,function:Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.,PTM:Autophosphorylated on serine and threonine residues.,sequence caution:Translated as Tyr.,sequence caution:Wrong choice of CDS.,similarity:Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily.,similarity:Contains 1 protein kinase domain.,subunit:Homodimer; forms dimers through the leucine-zipper motif. Interacts with the C-terminus of MAPK8IP
      • Subcellular Location:
      • Cytoplasm . Membrane ; Peripheral membrane protein .
      • Expression:
      • Expressed in the adult brain, liver, placenta and pancreas, with expression strongest in the pancreas.
      • Products Images
      • Western Blot analysis of various cells using LZK Polyclonal Antibody
      • Western Blot analysis of HepG2 cells using LZK Polyclonal Antibody
      • Western blot analysis of lysates from HeLa, HUVEC, and HepG2 cells, using M3K13 Antibody. The lane on the right is blocked with the synthesized peptide.
      • Western blot analysis of the lysates from HepG2 cells using M3K13 antibody.
      • Immunohistochemical analysis of paraffin-embedded human tonsil. 1, Tris-EDTA,pH9.0 was used for antigen retrieval. 2 Antibody was diluted at 1:200(4° overnight.3,Secondary antibody was diluted at 1:200(room temperature, 45min).